Jonathan L. Slaughter, MD, MPH

Jonathan L. Slaughter, MD, MPH is a principal investigator in the Center for Perinatal Research at The Research Institute at Nationwide Children’s Hospital and an Assistant Professor of Pediatrics at The Ohio State University. Dr. Slaughter's patient centered research program focuses on neonatal comparative effectiveness research to determine which treatments work best for neonatal patients given specific clinical circumstances and patient demographics.

View CV »

Gender:

• Male

Languages Spoken:

• English

Research Center:

• Center for Perinatal Research

Areas of Interest:

• Neonatal Global Health
• Newborn Screening
• My research goal is to improve neonatal care through rigorous comparative effectiveness research that will evaluate the risks and benefits of medications that, despite limited evidence, are commonly used in the treatment of prematurity-related disorders. Such medications include diuretics, acid suppressants, antiepileptics, inhaled steroids, bronchodilators, and non-steroidal anti-inflammatory drugs (NSAIDs). It is currently estimated that up to ninety percent of neonatal medication use is unapproved or off-label, and clinicians caring for infants must depend upon potentially dangerous extrapolations of adult trial findings. My patient-centered research aims to improve the outcomes of preterm infants by informing clinical practice decisions regarding medication administration.

Undergraduate School

• Catawba College, Salisbury, North Carolina
  Date Completed: 06/30/2000

Medical School

• Wake Forest University Baptist Medical Center
  Date Completed: 05/17/2004

Residency

• Medical University of South Carolina
  Date Completed: 06/30/2007

Fellowship

• Cincinnati Children's Hospital Medical Center
  Date Completed: 06/30/2010

Graduate School

• The Ohio State University
  Date Completed: 03/18/2012

Department:

• Pediatrics

Section:

• Neonatology

Speciality:

• Neonatal-Perinatal Medicine
  
• Pediatrics
  

Date of Appointment at Nationwide Children’s Hospital:

• 07/19/2010

• Slaughter J, Annibale D, Suresh G. False-negative results of pre-discharge neonatal bilirubin screening to predict severe hyperbilirubinemia: a need for caution. Eur J Pediatr. 2009;168(12):1461-1466. PubMed ID: 19255782
• Slaughter JL, Espinoza L, Molinero I, Wood T, Duron C, Flores A, Porter R, Tomashitis K, Holden KR. Utilization of blood-spot testing for metabolic-genetic disorders in Honduras: Is it time for newborn screening? J Child Neurol. 2010; 25(3): 306-311. PubMed ID: 19850562
• Slaughter JL, Meinzen-Derr J, Rose SR, Leslie ND, Chandrasekar R, Linard SM, Akinbi HT. The Effects of Gestation and Birth Weight on False-Positive Newborn Screening Rates. Pediatrics. 2010; 126(5): 910-916. PubMed ID: 20974783
• Stenger MR, Slaughter JL, Kelleher K, Shepherd EG, Klebanoff MA, Reagan P, Nelin LD, Gardner W. Hospital variation in nitric oxide use for premature infants. Pediatrics. 2012; 129: e945-e951.
• Slaughter JL, Pakrashi T, Jones DE, South AP, Shah TA. Echocardiographic Detection of Pulmonary Hypertension in Extremely Low Birth Weight Infants with Bronchopulmonary Dysplasia Requiring Prolonged Positive Pressure Ventilation. J Perinatol. 2011;31: 635-640. PubMed ID: 21311503